The role of RNA processing in the pathogenesis of motor neuron degeneration

Expert Reviews in Molecular Medicine

Volumn 12, Issue , 2010, Pages

  Bäumer, Dirk ^a   Ansorge, Olaf ^b   Almeida, Mara ^a   Talbot, Kevin ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

AMYOTROPHIC LATERAL SCLEROSIS; CELL STRUCTURE; GENE EXPRESSION; HUMAN; MOLECULAR PATHOLOGY; MOTONEURON; MOTOR NEURON DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA METABOLISM; RNA PROCESSING; RNA SPLICING; RNA TRANSCRIPTION; RNA TRANSPORT; SPINAL MUSCULAR ATROPHY; TRANSLATION REGULATION;

EID: 84862737980     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399410001523     Document Type: Review

References (222)

1. Lefebvre, S. et al. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165
2. Rosen, D.R. et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (Pubitemid 23087289)
3. Turner, B.J. and Talbot, K. (2008) Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Progress in Neurobiology 85, 94-134
4. Cleveland, D.W. and Rothstein, J.D. (2001) From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Reviews Neuroscience 2, 806-819 (Pubitemid 33674062)
5. Shaw, P.J. (2005) Molecular and cellular pathways of neurodegeneration in motor neurone disease. Journal of Neurology Neurosurgeryand Psychiatry 76, 1046-1057
6. Neumann, M. et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133 (Pubitemid 44547757)
7. Mackenzie, I.R. et al. (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Annals of Neurology 61, 427-434 (Pubitemid 46878770)
8. Sreedharan, J. et al. (2008) TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science 319, 1668-1672 (Pubitemid 351432505)
9. Vance, C. et al. (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211
10. Licatalosi, D.D. and Darnell, R.B (2010) RNA processing and its regulation: global insights into biological networks. Nature Reviews Genetics 11, 75-87
11. Ulfhake, B. and Kellerth, J.O. (1981) A quantitative light microscopic study of the dendrites of cat spinal alpha-motoneurons after intracellular staining with horseradish peroxidase. Journal of Comparative Neurology 202, 571-583 (Pubitemid 12216132)
12. Lemon, R.N. (2008) Descending pathways in motor control. Annual Review of Neuroscience 31, 195-218
13. Eisen, A. (2009) Amyotrophic lateral sclerosis-Evolutionary and other perspectives. Muscle and Nerve 40, 297-304
14. Pearn, J. (1978) Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. Journal of Medical Genetics 15, 409-413
15. Lefebvre, S. et al. (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nature Genetics 16, 265-269 (Pubitemid 27280210)
16. Schrank, B. et al. (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proceedings of the National Academy of Sciences of the United States of America 94, 9920-9925 (Pubitemid 27408166)
17. Cartegni, L., Chew, S.L. and Krainer, A.R. (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Reviews Genetics 3, 285-298 (Pubitemid 34279797)
18. Kashima, T. and Manley, J.L. (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nature Genetics 34, 460-463 (Pubitemid 36935342)
19. Monani, U.R. et al. (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Human Molecular Genetics 8, 1177-1183 (Pubitemid 29328985)
20. Lorson, C.L. et al. (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proceedings of the National Academy of Sciences of the United States of America 96, 6307-6311 (Pubitemid 29256661)
21. Wirth, B. et al. (1997) Different entities of proximal spinal muscular atrophy within one family. Human Genetics 100, 676-680 (Pubitemid 28072375)
22. Oprea, G.E. et al. (2008) Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320, 524-527 (Pubitemid 351590664)
23. McDermott, C.J. and Shaw, P.J. (2008) Diagnosis and management of motor neurone disease. British Medical Journal 336, 658-662 (Pubitemid 351481237)
24. Wijesekera, L.C. and Leigh, P.N. (2009) Amyotrophic lateral sclerosis. Orphanet Journal of Rare Diseases 4, 3
25. Strong, M.J. (2008) The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 9, 323-338
26. Mackenzie, I.R. and Feldman, H.H. (2005) Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum. Journal of Neuropathology and Experimental Neurology 64, 730-739 (Pubitemid 41177114)
27. Neary, D., Snowden, J.S. and Mann, D.M. (2000) Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS). Journal of the Neurological Sciences 180, 15-20
28. Arai, T. et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications 351, 602-611 (Pubitemid 44708852)
29. Gitcho, M.A. et al. (2008) TDP-43 A315T mutation in familial motor neuron disease. Annals of Neurology 63, 535-538 (Pubitemid 351614720)
30. Borroni, B. et al. (2009) Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. Human Mutation 30, E974-983
31. Chiò, A et al. (2008) Prevalence of SOD1 mutations in the Italian ALS population. Neurology. 70, 533-7 (Pubitemid 351653378)
32. O'Toole, O. et al. (2008) Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. Journal of Neurology Neurosurgery and Psychiatry 79, 30-32
33. Greenway, M.J. et al. (2006) ANG mutations segregate with familial and 'sporadic'amyotrophic lateral sclerosis. Nature Genetics 38, 411-413
34. Schymick, J.C., Talbot, K. and Traynor, B.J. (2007) Genetics of sporadic amyotrophic lateral sclerosis. Human Molecular Genetics 16 Spec No. 2, R233-242
35. Ravits, J.M. and La Spada, A.R. (2009) ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73, 805-811
36. James, P.A. and Talbot, K. (2006) The molecular genetics of non-ALS motor neuron diseases. Biochimica et Biophysica Acta 1762, 986-1000 (Pubitemid 44750576)
37. Lee, C.J. and Irizarry, K. (2003) Alternative splicing in the nervous system: an emerging source of diversity and regulation. Biological Psychiatry 54, 771-776 (Pubitemid 37205128)
38. Li, Q., Lee, J.A. and Black, D.L. (2007) Neuronal regulation of alternative pre-mRNA splicing. Nature Reviews Neuroscience 8, 819-831 (Pubitemid 350006218)
39. Wojtowicz, W.M. et al. (2004) Alternative splicing of Drosophila Dscam generates axon guidance receptors that exhibit isoform-specific homophilic binding. Cell 118, 619-633 (Pubitemid 39179714)
40. Matthews, B.J. et al. (2007) Dendrite self-avoidance is controlled by Dscam. Cell 129, 593-604 (Pubitemid 46660975)
41. Boucard, A.A. et al. (2005) A splice code for transsynaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 48, 229-236 (Pubitemid 41476357)
42. Chih, B., Engelman, H. and Scheiffele, P. (2005) Control of excitatory and inhibitory synapse formation by neuroligins. Science 307, 1324-1328 (Pubitemid 40299984)
43. Chih, B., Gollan, L. and Scheiffele, P. (2006) Alternative splicing controls selective transsynaptic interactions of the neuroligin-neurexin complex. Neuron 51, 171-178 (Pubitemid 44063616)
44. Raingo, J., Castiglioni, A.J. and Lipscombe, D. (2007) Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nature Neuroscience 10, 285-292
45. Wahl, M.C., Will, C.L. and Luhrmann, R. (2009) The spliceosome: design principles of a dynamic RNP machine. Cell 136, 701-718
46. Will, C.L. and Luhrmann, R. (2005) Splicing of a rare class of introns by the U12-dependent spliceosome. Biological Chemistry 386, 713-724 (Pubitemid 41448152)
47. Meister, G. et al. (2001) A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs. Nature Cell Biology 3, 945-949 (Pubitemid 34428738)
48. Pellizzoni, L., Yong, J. and Dreyfuss, G. (2002) Essential role for the SMN complex in the specificity of snRNP assembly. Science 298, 1775-1779 (Pubitemid 35404118)
49. Yang, Y.Y., Yin, G.L. and Darnell, R.B. (1998) The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proceedings of the National Academy of Sciences of the United States of America 95, 13254-13259 (Pubitemid 28509558)
50. Jensen, K.B. et al. (2000) Nova-1 regulates neuronspecific alternative splicing and is essential for neuronal viability. Neuron 25, 359-371
51. Ule, J. et al. (2006) An RNA map predicting Nova-dependent splicing regulation. Nature 444, 580-586 (Pubitemid 44864431)
52. Ule, J. et al. (2005) Nova regulates brain-specific splicing to shape the synapse. Nature Genetics 37, 844-852 (Pubitemid 41077110)
53. Ruggiu, M. et al. (2009) Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proceedings of the National Academy of Sciences of the United States of America 106, 3513-3518
54. Buratti, E. and Baralle, F.E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. Journal of Biological Chemistry 276, 36337-36343
55. Buratti, E. et al. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO Journal 20, 1774-1784 (Pubitemid 32299413)
56. Buratti, E. et al. (2004) Nuclear factor TDP-43 binds to the polymorphicTGrepeats inCFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. American Journal of Human Genetics 74, 1322-1325 (Pubitemid 38669335)
57. Ayala, Y.M., Pagani, F. and Baralle, F.E. (2006) TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Letters 580, 1339-1344 (Pubitemid 43221997)
58. Mercado, P.A. et al. (2005) Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucleic Acids Research 33, 6000-6010 (Pubitemid 41742619)
59. D'Ambrogio, A. et al. (2009) Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res 37, 4116-4126
60. Ayala, Y.M., Misteli, T. and Baralle, F.E. (2008) TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proceedings of the National Academy of Sciences of the United States of America 105, 3785-3789 (Pubitemid 351723476)
61. Bose, J.K. et al. (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. Journal of Biological Chemistry 283, 28852-28859
62. Iko, Y. et al. (2004) Domain architectures and characterization of an RNA-binding protein, TLS. Journal of Biological Chemistry 279, 44834-44840 (Pubitemid 39430895)
63. Yang, L. et al. (1998) Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. Journal of Biological Chemistry 273, 27761-27764 (Pubitemid 28496059)
64. Meissner, M. et al. (2003) Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Experimental Cell Research 283, 184-195 (Pubitemid 36269024)
65. Sato, S. et al. (2005) beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology 129, 1225-1236 (Pubitemid 41446862)
66. Yang, L., Embree, L.J. and Hickstein, D.D. (2000) TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Molecular and Cellular Biology 20, 3345-3354 (Pubitemid 30243880)
67. Lerga, A. et al. (2001) Identification of an RNA binding specificity for the potential splicing factor TLS. Journal of Biological Chemistry 276, 6807-6816
68. Davidson, Y. et al. (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathologica 113, 521-533 (Pubitemid 46672598)
69. Cairns, N.J. et al. (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. American Journal of Pathology 171, 227-240 (Pubitemid 47342406)
70. Kwiatkowski, T.J., Jr. et al. (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208
71. Neumann, M. et al. (2009) A new sub-type of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922-2931
72. Feiguin, F. et al. (2009) Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett 583, 1586-1592
73. Andersson, M.K. et al. (2008) The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biology 9, 37
74. Aman, P. et al. (1996) Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 37, 1-8 (Pubitemid 26341827)
75. Gabanella, F. et al. (2005) The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation. Human Molecular Genetics 14, 3629-3642 (Pubitemid 41754664)
76. Gabanella, F. et al. (2007) Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severityand preferentiallyaffect a subset of spliceosomal snRNPs. PLoS One 2, e921
77. Zhang, Z. et al. (2008) SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133, 585-600 (Pubitemid 351636302)
78. Baumer, D. et al. (2009) Alternative splicing events are alte feature of pathology ina mouse model of spinal muscular atrophy. PLoS Genetics 5, e1000773.
79. Xiao, S. et al. (2008) An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology. Journal of Neuroscience 28, 1833-1840 (Pubitemid 351302676)
80. Rabin, S. et al. (2010) Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology. Human Molecular Genetics 19, 313-328
81. Martin, K.C. and Zukin, R.S. (2006) RNA trafficking and local protein synthesis in dendrites: an overview. Journal of Neuroscience 26, 7131-7134
82. Giorgi, C. and Moore, M.J. (2007) The nuclear nurture and cytoplasmic nature of localized mRNPs. Seminars in Cell and Developmental Biology 18, 186-193 (Pubitemid 46756360)
83. Oleynikov, Y. and Singer, R.H. (2003) Real-time visualization of ZBP1 association with beta-actin mRNA during transcription and localization. Current Biology 13, 199-207 (Pubitemid 36178297)
84. di Penta, A. et al. (2009) Dendritic LSm1/CBP80-mRNPs mark the early steps of transport commitment and translational control. Journal of Cell Biology 184, 423-435
85. Gu, W. et al. (2002) A predominantly nuclear protein affecting cytoplasmic localization of betaactin mRNA in fibroblasts and neurons. Journal of Cell Biology 156, 41-51 (Pubitemid 34846934)
86. Ross, A.F. et al. (1997) Characterization of a beta-actin mRNA zipcode-binding protein. Molecular and Cellular Biology 17, 2158-2165 (Pubitemid 27133302)
87. Condeelis, J. and Singer, R.H. (2005) Howand why does beta-actin mRNA target? Biology of the Cell 97, 97-110 (Pubitemid 40220716)
88. Tiruchinapalli, D.M. et al. (2003) Activity-dependent trafficking and dynamic localization of zipcode binding protein 1 and beta-actin mRNA in dendrites and spines of hippocampal neurons. Journal of Neuroscience 23, 3251-3261 (Pubitemid 36531966)
89. Zhang, H.L. et al. (2001) Neurotrophin-induced transport of a beta-actin mRNP complex increases beta-actin levels and stimulates growth cone motility. Neuron 31, 261-275 (Pubitemid 32762979)
90. Knowles, R.B. et al. (1996) Translocation of RNA granules in living neurons. Journal of Neuroscience 16, 7812-7820 (Pubitemid 26405044)
91. Krichevsky, A.M. and Kosik, K.S. (2001) Neuronal RNA granules: a link between RNA localization and stimulation-dependent translation. Neuron 32, 683-696 (Pubitemid 33145201)
92. Kiebler, M.A. and Bassell, G.J. (2006)NeuronalRNA granules: movers and makers. Neuron 51, 685-690
93. Martin, K.C. and Ephrussi, A. (2009) mRNA localization: gene expression in the spatial dimension. Cell 136, 719-730
94. Elvira, G. et al. (2006) Characterization of an RNA granule from developing brain. Molecular and Cellular Proteomics 5, 635-651
95. Kiebler, M.A. et al. (1999) The mammalian staufen protein localizes to the somatodendritic domain of cultured hippocampal neurons: implications for its involvement in mRNA transport. Journal of Neuroscience 19, 288-297 (Pubitemid 29028969)
96. Kanai, Y., Dohmae, N. and Hirokawa, N. (2004) Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 43, 513-525 (Pubitemid 39094678)
97. Landers, J.E. et al. (2009) Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America 106, 9004-9009
98. Munch, C. et al. (2004) Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63, 724-726 (Pubitemid 39100836)
99. Munch, C. et al. (2005) Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD. Annals of Neurology 58, 777-780 (Pubitemid 41552554)
100. Puls, I. et al. (2003) Mutant dynactin in motor neuron disease. Nature Genetics 33, 455-456 (Pubitemid 36390002)
101. Fujii, R. et al. (2005) TheRNAbinding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Current Biology 15, 587-593 (Pubitemid 40413401)
102. Fujii, R. and Takumi, T. (2005) TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. Journal of Cell Science 118, 5755-5765 (Pubitemid 43079269)
103. Yoshimura, A. et al. (2006) Myosin-Va facilitates the accumulation of mRNA/protein complex in dendritic spines. Current Biology 16, 2345-2351 (Pubitemid 44821840)
104. Fan, L. and Simard, L.R. (2002) Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development. Human Molecular Genetics 11, 1605-1614 (Pubitemid 34812256)
105. Rossoll, W. et al. (2002) Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons? Human Molecular Genetics 11, 93-105 (Pubitemid 34100772)
106. Jablonka, S. et al. (2001) Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy. Human Molecular Genetics 10, 497-505 (Pubitemid 32181672)
107. Bechade, C. et al. (1999) Subcellular distribution of survival motor neuron (SMN) protein: possible involvement in nucleocytoplasmic and dendritic transport. European Journal of Neuroscience 11, 293-304 (Pubitemid 29012332)
108. Pagliardini, S. et al. (2000) Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Human Molecular Genetics 9, 47-56 (Pubitemid 30145287)
109. Briese, M. et al. (2006) SMN, the product of the spinal muscular atrophy-determining gene, is expressed widely but selectively in the developing human forebrain. Journal of Comparative Neurology 497, 808-816 (Pubitemid 43993444)
110. Giavazzi, A. et al. (2006) Neuronal-specific roles of the survival motor neuron protein: evidence from survival motor neuron expression patterns in the developing human central nervous system. Journal of Neuropathology and Experimental Neurology 65, 267-277
111. Rossoll, W. and Bassell, GJ (2009) Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes. Results and Problems in Cell Differentiation. 48, 289-326
112. McWhorter, M.L. et al. (2003) Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. Journal of Cell Biology 162, 919-931 (Pubitemid 37087731)
113. Rossoll, W. et al. (2003) Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. Journal of Cell Biology 163, 801-812 (Pubitemid 37517887)
114. Zhang, H. et al. (2006) Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons. Journal of Neuroscience 26, 8622-8632 (Pubitemid 44316191)
115. Meister, G., Eggert, C. and Fischer, U. (2002) SMN-mediated assembly of RNPs: a complex story. Trends in Cell Biology 12, 472-478 (Pubitemid 35346518)
116. Luo, L. (2002) Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity. Annual Reviewof Cell and Developmental Biology 18, 601-635
117. Strong, M.J. et al. (2007) TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Molecular and Cellular Neurosciences 35, 320-327 (Pubitemid 46843567)
118. Wang, I.F. et al. (2008) TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. Journal of Neurochemistry 105, 797-806
119. Lu, L. et al. (2007) Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression. Journal of Neuroscience 27, 7929-7938 (Pubitemid 47173324)
120. Li, X. et al. (2009) Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3′-untranslated region. Journal of Neurochemistry 108, 1032-1044
121. Ge, W.W. et al. (2005) Mutant copper-zinc superoxide dismutase binds to and destabilizes human low molecular weight neurofilament mRNA. Journal of Biological Chemistry 280, 118-124
122. Volkening, K. et al. (2009) TarDNAbinding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Research 1305, 168-182
123. Besse, F. and Ephrussi, A. (2008) Translational control of localized mRNAs: restricting protein synthesis in space and time. Nature Reviews Molecular Cell Biology 9, 971-980
124. Napoli, I. et al. (2008) The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134, 1042-1054
125. Huttelmaier, S. et al. (2005) Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature 438, 512-515 (Pubitemid 41742024)
126. Huang, Y.S. et al. (2002) N-methyl-D-aspartate receptor signaling results in Aurora kinase-catalyzed CPEB phosphorylation and alpha CaMKII mRNA polyadenylation at synapses. EMBO Journal 21, 2139-2148
127. Koenig, E. and Martin, R. (1996) Cortical plaque-like structures identify ribosome-containing domains in the Mauthner cell axon. Journal of Neuroscience 16, 1400-1411 (Pubitemid 26145920)
128. Koenig, E. et al. (2000) Cryptic peripheral ribosomal domains distributed intermittently along mammalian myelinated axons. Journal of Neuroscience 20, 8390-8400
129. Merianda, T.T. et al. (2009) A functional equivalent of endoplasmic reticulum and Golgi in axons for secretion of locally synthesized proteins. Molecular and Cellular Neurosciences 40, 128-142
130. Lin, A.C. and Holt, C.E. (2008) Function and regulation of local axonal translation. Current Opinion in Neurobiology 18, 60-68
131. Giuditta, A. et al. (2008) Local gene expression in axons and nerve endings: the glia-neuron unit. Physiological Reviews 88, 515-555 (Pubitemid 351520087)
132. Leung, K.M. et al. (2006) Asymmetrical beta-actin mRNA translation in growth cones mediates attractive turning to netrin-1. Nature Neuroscience 9, 1247-1256
133. Lin, A.C. and Holt, C.E. (2007) Local translation and directional steering in axons. EMBO Journal 26, 3729-3736 (Pubitemid 47295875)
134. Hanz, S. et al. (2003) Axoplasmic importins enable retrograde injury signaling in lesioned nerve. Neuron 40, 1095-1104 (Pubitemid 38032787)
135. Yudin, D. et al. (2008) Localized regulation of axonal RanGTPase controls retrograde injury signaling in peripheral nerve. Neuron 59, 241-252 (Pubitemid 352033684)
136. Taylor, A.M. et al. (2009) Axonal mRNA in uninjured and regenerating cortical mammalian axons. Journal of Neuroscience 29, 4697-4707
137. Willis, D. et al. (2005) Differential transport and local translation of cytoskeletal, injury-response, and neurodegeneration protein mRNAs in axons. Journal of Neuroscience 25, 778-791 (Pubitemid 40170992)
138. Jimenez-Diaz, L. et al. (2008) Local translation in primary afferent fibers regulates nociception. PLoS One 3, e1961
139. Yoo, S. et al. (2010) Dynamics of axonal mRNA transport and implications for peripheral nerve regeneration. Experimental Neurology 223, 19-27
140. Antonellis, A. et al. (2003) Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. American Journal of HumanGenetics 72, 1293-1299 (Pubitemid 36530017)
141. Jordanova, A. et al. (2006) Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nature Genetics 38, 197-202 (Pubitemid 43177233)
142. Antonellis, A. and Green, E.D. (2008) The role of aminoacyl-tRNA synthetases in genetic diseases. Annual Review of Genomics and Human Genetics 9, 87-107
143. Motley, W., Talbot, K. and Fischbeck, K. (2010) GARS axonopathy - not every neuron's cup of tRNA Trends in Neuroscience 33, 59-66
144. Chihara, T., Luginbuhl, D. and Luo, L. (2007) Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization. Nature Neuroscience 10, 828-837 (Pubitemid 47013428)
145. Grohmann, K. et al. (2001) Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nature Genetics 29, 75-77 (Pubitemid 32801813)
146. Grohmann, K. et al. (2004) Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1). Human Molecular Genetics 13, 2031-2042 (Pubitemid 39377827)
147. Guenther, U.P. et al. (2009) IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1). Human Molecular Genetics 18, 1288-1300
148. Chen, Y.Z. et al. (2004) DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). American Journal of Human Genetics 74, 1128-1135
149. Suraweera, A. et al. (2007) Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage. Journal of Cell Biology 177, 969-979 (Pubitemid 46955702)
150. Suraweera, A. et al. (2009) Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Human Molecular Genetics 18, 3384-3396
151. Chen, Y.Z. et al. (2006) Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease. Neurobiology of Disease 23, 97-108
152. Tsai, N.P., Tsui, Y.C. and Wei, L.N. (2009) Dynein motor contributes to stress granule dynamics in primary neurons. Neuroscience 159, 647-656
153. DeGracia, D.J. et al. (2007) Convergence of stress granules and protein aggregates in hippocampal cornu ammonis 1 at later reperfusion following global brain ischemia. Neuroscience 146, 562-572 (Pubitemid 46621138)
154. Anderson, P. and Kedersha, N. (2008) Stress granules: the Tao of RNA triage. Trends in Biochemical Sciences 33, 141-150
155. Anderson, P. and Kedersha, N. (2006) RNA granules. Journal of Cell Biology 172, 803-808
156. Kawai, T. et al. (2004) Global mRNA stabilization preferentially linked to translational repression during the endoplasmic reticulum stress response. Molecular and Cellular Biology 24, 6773-6787 (Pubitemid 38944356)
157. Harding, H.P. et al. (2002) Transcriptional and translational control in the Mammalian unfolded protein response. Annual Review of Cell and Developmental Biology 18, 575-599 (Pubitemid 35387362)
158. Harding, H.P. et al. (2003) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Molecular Cell 11, 619-633 (Pubitemid 36385118)
159. Kedersha, N. et al. (2002) Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents
160. Ayala, Y.M. et al. (2008) Structural determinants of the cellular localization and shuttling of TDP-43. Journal of Cell Science 121, 3778-3785
161. Zinszner, H. et al. (1997) TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. Journal of Cell Science 110, 1741-1750 (Pubitemid 27352853)
162. Kedersha, N. et al. (2000) Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. Journal of Cell Biology 151, 1257-1268
163. Taupin, J.L. et al. (1995) The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proceedings of the National Academy of Sciences of the United States of America 92, 1629-1633
164. Gallouzi, I.E. et al. (2000) HuR binding to cytoplasmic mRNA is perturbed by heat shock. Proceedings of the National Academy of Sciences of the United States of America 97, 3073-3078
165. Moisse, K. et al. (2009) Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. Brain Res 1249, 202-211
166. Moisse, K. et al. (2009) Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL(-/-) mice: Support for a role for TDP-43 in the physiological response to neuronal injury. Brain Res 1296, 176-86
167. Colombrita, C. et al. (2009) TDP-43 is recruited to stress granules in conditions of oxidative insult. Journal of Neurochemistry 111, 1051-61
168. Fujita, K. et al. (2008) Immunohistochemical identification of messenger RNA-related proteins in basophilic inclusions of adult-onset atypical motor neuron disease. Acta Neuropathol 116, 439-445
169. Munoz, D.G. et al. (2009) FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118, 617-627
170. McEwen, E. et al. (2005) Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. Journal of Biological Chemistry 280, 16925-16933 (Pubitemid 41389152)
171. Mazroui, R. et al. (2006) Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Molecular Biology of the Cell 17, 4212-4219 (Pubitemid 44522042)
172. Yamasaki, S. et al. (2009) Angiogenin cleaves tRNA and promotes stress-induced translational repression. Journal of Cell Biology 185, 35-42
173. Gellera, C. et al. (2008) Identification of new ANG gene mutations in a large cohort of Italian patients withamyotrophic lateral sclerosis. Neurogenetics 9, 33-40
174. Crabtree, B. et al. (2007) Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry 46, 11810-11818 (Pubitemid 47623749)
175. Subramanian, V., Crabtree, B. and Acharya, K.R. (2008) Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons.Human Molecular Genetics 17, 130-149
176. Hua, Y. and Zhou, J. (2004) Rpp20 interacts with SMN and is re-distributed into SMN granules in response to stress. Biochemical and Biophysical Research Communications 314, 268-276 (Pubitemid 38058396)
177. Hua, Y. and Zhou, J. (2004) Survival motor neuron protein facilitates assembly of stress granules. FEBS Lett 572, 69-74 (Pubitemid 39092515)
178. Cougot, N. et al. (2008) Dendrites of mammalian neurons contain specialized P-body-like structures that respond to neuronal activation. Journal of Neuroscience 28, 13793-13804
179. Zeitelhofer, M., Macchi, P. and Dahm, R. (2008) Perplexing bodies: The putative roles of P-bodies in neurons. RNA Biol 5, 244-248
180. Zeitelhofer, M. et al. (2008) Dynamic interaction between P-bodies and transport ribonucleoprotein particles in dendrites of mature hippocampal neurons. Journal of Neuroscience 28, 7555-7562
181. Brengues, M., Teixeira, D. and Parker, R. (2005) Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science 310, 486-489 (Pubitemid 41507961)
182. Cougot, N., Babajko, S. and Seraphin, B. (2004) Cytoplasmic foci are sites of mRNA decay in human cells. Journal of Cell Biology 165, 31-40 (Pubitemid 38649174)
183. Sheth, U. and Parker, R. (2006) Targeting of aberrant mRNAsto cytoplasmic processing bodies. Cell 125, 1095-1109 (Pubitemid 43866203)
184. Anderson, P. and Kedersha, N. (2009) RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nature Reviews Molecular Cell Biology 10, 430-436
185. Parker, R. and Sheth, U. (2007) P bodies and the control of mRNA translation and degradation. Molecular Cell 25, 635-646 (Pubitemid 46341926)
186. Gregory, R.I. et al. (2004) The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240 (Pubitemid 39545855)
187. Bicker, S. and Schratt, G. (2008) microRNAs: tiny regulators of synapse function in development and disease. Journal of Cellular and Molecular Medicine 12, 1466-1476
188. Carthew, R.W. and Sontheimer, E.J. (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136, 642-655
189. Kosik, K.S. (2006) The neuronal microRNA system. Nature Reviews Neuroscience 7, 911-920
190. Schaefer, A. et al. (2007) Cerebellar neurodegeneration in the absence of microRNAs. Journal of Experimental Medicine 204, 1553-1558 (Pubitemid 47048023)
191. Damiani, D. et al. (2008) Dicer inactivation leads to progressive functional and structural degeneration of the mouse retina. Journal of Neuroscience 28, 4878-4887
192. Kim, J. et al. (2007) A MicroRNA feedback circuit in midbraindopamine neurons. Science 317, 1220-1224
193. Li, X. and Jin, P. (2009) Macro role(s) of microRNAs in fragile X syndrome? Neuromolecular Medicine 11, 200-207
194. Abelson, J.F. et al. (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310, 317-320 (Pubitemid 41457198)
195. Lukiw, W.J. (2007) Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18, 297-300
196. Bilen, J., Liu, N. and Bonini, N.M. (2006)A new role for microRNA pathways: modulation of degeneration induced by pathogenic human disease proteins. Cell Cycle 5, 2835-2838 (Pubitemid 44953931)
197. Bilen, J. et al. (2006) MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Molecular Cell 24, 157-163 (Pubitemid 44466675)
198. Gass, J. et al. (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Human Molecular Genetics 15, 2988-3001 (Pubitemid 44530703)
199. Rademakers, R. et al. (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Human Molecular Genetics 17, 3631-3642
200. Bass, B.L. (2002) RNA editing by adenosine deaminases that act on RNA. Annual Review of Biochemistry 71, 817-846
201. Greger, I.H. et al. (2003) AMPA receptor tetramerization is mediated by Q/R editing. Neuron 40, 763-774 (Pubitemid 37431036)
202. Burnashev, N. et al. (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8, 189-198
203. Kawahara, Y. et al. (2004) Glutamate receptors: RNA editing and death ofmotor neurons. Nature 427, 801
204. Kwak, S. and Kawahara, Y. (2005) Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. Journal of Molecular Medicine 83, 110-120 (Pubitemid 40379299)
205. Wamer, W.G., Yin, J.J. and Wei, R.R. (1997) Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radical Biology and Medicine 23, 851-858 (Pubitemid 27402610)
206. Tanaka, M., Chock, P.B. and Stadtman, E.R. (2007) Oxidized messenger RNA induces translation errors. Proceedings of the National Academy of Sciences of the United States of America 104, 66-71 (Pubitemid 46067985)
207. Shan, X., Chang, Y. and Lin, C.L. (2007) Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression. FASEB Journal 21, 2753-2764 (Pubitemid 47372743)
208. Nunomura, A. et al. (2009) RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol 118, 151-166
209. Chang, Y. et al. (2008) Messenger RNA oxidation occurs early in disease pathogenesis and promotes motorneurondegenerationinALS.PLoSOne3, e2849
210. Strasswimmer, J. et al. (1999) Identification of survival motor neuron as a transcriptional activator-binding protein. Human Molecular Genetics 8, 1219-1226 (Pubitemid 29328990)
211. Pellizzoni, L. et al. (2001) A functional interaction between the survival motor neuron complex and RNA polymerase II. Journal of Cell Biology 152, 75-85 (Pubitemid 32102438)
212. Winkler, C. et al. (2005) Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes and Development 19, 2320-2330 (Pubitemid 41396909)
213. Antonellis, A. et al. (2006) Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons. Journal of Neuroscience 26, 10397-10406 (Pubitemid 44564590)
214. Nousiainen, H.O. et al. (2008) Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease. Nature Genetics 40, 155-157 (Pubitemid 351171396)
215. Bolger, T.A. et al. (2008) The mRNA export factor Gle1 and inositol hexakisphosphate regulate distinct stages of translation. Cell 134, 624-633
216. Ou, S.H. et al. (1995) Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. Journal of Virology 69, 3584-3596
217. Abhyankar, M.M., Urekar, C. and Reddi, P.P. (2007) A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues: role for TDP-43 in insulator function. Journal of Biological Chemistry 282, 36143-36154
218. Wang, X. et al. (2008) Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454, 126-130 (Pubitemid 351934270)
219. Xu, Z.P. et al. (2003) Identification and characterization of an angiogenin-binding DNA sequence that stimulates luciferase reporter gene expression. Biochemistry 42, 121-128
220. Xu, Z.P. et al. (2002) The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochemical and Biophysical Research Communications 294, 287-292
221. Tsuji, T. et al. (2005) Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomalRNAtranscription and cell proliferation. Cancer Research 65, 1352-1360 (Pubitemid 40270162)
222. Saxena, S.K. et al. (1992) Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily. Journal of Biological Chemistry 267, 21982-21986666